A key to ‘winning’ in today’s market — and other trends pharma leaders are tracking

Healthcare pros share the market drivers they believe are having the biggest impact on the industry.

By Taren Grom • June 2, 2023

How Takeda finds the hottest new science to fuel its oncology work

Takeda's president of the global oncology business unit is always "scanning the horizon" for the partnerships that will drive the next big innovations.

By Michael Gibney • June 1, 2023

Explore the Trendline➔

Cell and gene therapies

How the industry is overcoming hurdles in cell and gene therapy space and pushing for the next generation of treatments.

By PharmaVoice staff

Woman of the Week: Mirati Therapeutics’ Laurie Stelzer

With the recent approval of Krazati, the biotech veteran is guiding Mirati into its next phase as a commercial organization.

By Taren Grom • May 31, 2023

The ‘superpowers’ pharma leaders should cultivate

Executives honored by the Healthcare Businesswomen’s Association share the key traits that help them drive results.

By Taren Grom • May 26, 2023

Woman of the Week: Cognition Therapeutics’ Lisa Ricciardi

As CEO of the neurogenerative company, Ricciardi is applying her decades of “human capital” to advance Alzheimer’s and dementia treatments.

By Taren Grom • May 24, 2023

How biopharma executives fight burnout

Pharma leaders share what they do to keep their teams from fizzling out.

By Taren Grom • May 19, 2023

What pharma can teach biotech about the life cycle management of a drug

Global product teams are common in pharma but have yet to gain traction in biotech. Here's why this model can work.

By Dr. Stephen Dale and Kathleen Ford • May 18, 2023

Woman of the Week: Genentech’s Veronica Sandoval

How the Genentech diversity exec is using ‘three Ms’ to reduce health disparities and improve access for under-supported communities.

By Taren Grom • May 17, 2023

A day in the life of a pharma exec: Lyndra’s Patricia Hurter

How the CEO starts each day with a ride on one of her horses, reduces daily meetings and uses her network to get through crises like the SVB Bank collapse.

By Meagan Parrish • May 17, 2023

Woman of the Week: Reneo Pharmaceuticals’ Ashley Hall

After ushering a blockbuster to market, the chief development officer is channeling her experience into the rare disease space.

By Taren Grom • May 10, 2023

AbbVie’s Christopher Boone on RWE’s potential — and its ‘profound ethical dilemmas’

With decades of experience in public health, Boone is leveraging RWE to move the needle within clinical development.

By Taren Grom • May 10, 2023

This ‘hot-blooded’ CEO is aiming to transform the way burn victims heal

Cutiss CEO Daniela Marino is funneling her bold personality and expertise in regenerative medicine into a startup developing bioengineered skin grafts.

By Alexandra Pecci • May 9, 2023

How Immunocore’s Bahija Jallal embraced the ‘a-ha’ moment of promising science

The biotech CEO is bullish on the company’s pioneering T cell receptor platform and innovating new immunology-based treatments.

By Taren Grom • May 5, 2023

A biopharma CEO opens up about executive salaries — and why he wants to change the status quo

With leaders at the biggest biopharma companies bringing in millions, the CEO of Corvus Pharmaceuticals opted for a pay cut to pour more funds into science.

By Michael Gibney • May 4, 2023

Navigating workforce challenges amid a turbulent biopharma market

A number of biopharma companies slashed their workforces this year and as market anxieties persist, more challenges could be looming.

By Karissa Waddick • May 4, 2023

Woman of the Week: Jazz Pharmaceuticals’ Neena Patil

Patil’s dual interests in healthcare and law are at the intersection of her C-suite role.

By Taren Grom • May 3, 2023

Attracting up-and-coming talent in biotech

The CEO of a Bay-area startup shares his strategies for growing a team from the ground up.

By Meagan Parrish • May 3, 2023

From science to strategy, this exec is painting Genmab’s bigger picture into the next decade

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

By Michael Gibney • May 2, 2023

A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient

The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.

By Taren Grom • May 1, 2023

5 minutes with — DTRA’s Dr. Amir Kalali

An industry veteran, innovator and curator, Dr. Amir Kalali discusses the high points of his career and his go-to productivity hack.

By Taren Grom • April 28, 2023

BMS’s CEO transition will be a major test for the pharma giant

Come November, Chris Boerner will take the top spot as the company approaches patent cliffs for three drugs in the next decade.

By Karissa Waddick • April 28, 2023

Pharma’s immunology field is full of blockbusters, and it’s just getting started

From the "father" of the IL-23 pathway at Janssen to a big acquisition by Merck, the ultra-competitive immunology space is still growing with the pace of innovation.

By Michael Gibney • April 27, 2023

Roy Vagelos is retiring and leaving a legacy of leadership lessons

The longtime pharma leader is stepping down from his role as chair of Regeneron’s board in June after decades in drug development. 

By Karissa Waddick • April 25, 2023

The 99 seconds that changed this CEO’s life

Peter Kirk’s marathon story of inspiration and perseverance.

By Taren Grom • April 21, 2023

Cure Ventures has $350M to pour deep into biotech ‘company building’

The biotech venture capital firm Cure Ventures, led by three industry veterans, raised the inaugural fund in early April and will soon announce its seed companies.

By Michael Gibney • April 20, 2023